Literature DB >> 21404913

Rheumatic heart disease: mediation by complex immune events.

L Guilherme1, K F Köhler, J Kalil.   

Abstract

Rheumatic fever (RF) is an autoimmune disease caused by the Gram-positive bacteria Streptococcus pyogenes following an untreated throat infection in susceptible children. Rheumatic heart disease (RHD), the most serious complication, occurs in 30-45% of RF patients and leads to chronic valvular lesions. Here, we focus on the genes that confer susceptibility for developing this disease. Molecular mimicry mediates the cross-reactions between streptococcal antigens and human proteins. Several autoantigens have been identified, including cardiac myosin epitopes, vimentin, and other intracellular proteins. In heart tissue, antigen-driven oligoclonal T cell expansions probably cause the rheumatic heart lesions. These cells are CD4+ and produce inflammatory cytokines (TNF alpha and IFN gamma). IL-4+ cells are found in the myocardium; however, these cells are very scarce in the valve lesions of RHD patients. IL-4 is a Th2-type cytokine and plays a regulatory role in the inflammatory response mediated by Th1 cytokines. Our findings indicate that the Th1/Th2 cytokine balance has a role in healing myocarditis while the low numbers of IL-4-producing cells in the valves probably induced the progressive and permanent valve damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21404913

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  24 in total

Review 1.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 2.  Mitral Valve Pathology.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-05-23       Impact factor: 2.931

Review 3.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  The HLA Class II Associations with Rheumatic Heart Disease in South Indian Patients: A Preliminary Study.

Authors:  Divya Bajoria; Thangam Menon
Journal:  J Clin Diagn Res       Date:  2013-02-01

Review 5.  Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases.

Authors:  Kamal M Kassem; Mahboob Ali; Nour-Eddine Rhaleb
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-08-11       Impact factor: 2.457

Review 6.  Mechanistic implications of altered protein expression in rheumatic heart disease.

Authors:  Evelyn N Lumngwena; Sebastian Skatulla; Jonathan M Blackburn; Ntobeko A B Ntusi
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 7.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 8.  Relevance of molecular mimicry in the mediation of infectious myocarditis.

Authors:  Chandirasegaran Massilamany; Sally A Huber; Madeleine W Cunningham; Jay Reddy
Journal:  J Cardiovasc Transl Res       Date:  2013-11-22       Impact factor: 4.132

Review 9.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

10.  StreptInCor: a candidate vaccine epitope against S. pyogenes infections induces protection in outbred mice.

Authors:  Edilberto Postol; Raquel Alencar; Fabio T Higa; Samar Freschi de Barros; Lea M F Demarchi; Jorge Kalil; Luiza Guilherme
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.